Simon Property Group Inc /DE/ — 13F Filings Deep Dive
Simon Property Group Inc /DE/
CIK: 0001063761
Long-term holder
Total reported value
—
Reporting period: 2016-09-30 · Number of holdings: 1
Simon Property Group Inc /DE/ disclosed 1 holdings in its latest 13F filing for the period ending 2016-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Not enough priced holdings yet to compute performance
Position changes disclosed by Simon Property Group Inc /DE/ for the quarter ending 2016-09-30, including ticker, issuer, weight change, shares change, and action
What is Simon Property Group Inc /DE/ and what type of investor is it?
Simon Property Group Inc /DE/ is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2016-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Simon Property Group Inc /DE/'s largest equity positions?
Based on the latest 13F filing, Simon Property Group Inc /DE/'s top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Simon Property Group Inc /DE/ make in its most recent portfolio filing?
No notable portfolio changes were recorded for Simon Property Group Inc /DE/ in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Simon Property Group Inc /DE/ focus on?
Sector breakdown data is not yet available for Simon Property Group Inc /DE/. Check back after the next 13F processing cycle.